A practical checklist for deciding on Ozempic with your doctor, from label warnings and trial data to costs and long-term tracking.
Is Ozempic worth it? The honest answer starts with another question: worth it for what? Ozempic (semaglutide) is a once-weekly pen, and whether it makes sense for you depends on why you're considering it and what your history looks like. Our Portuguese post covers the general criteria, so this guide focuses on the practical side: what to bring to the appointment, how to ask better questions, and how to keep track once you start.
Start with what “worth it” means for you
The answer depends heavily on the indication. In the US, Ozempic is approved for adults with type 2 diabetes to improve blood sugar control, alongside diet and exercise. It has a separate indication to lower the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease. Wegovy is a different product with its own label, approved for chronic weight management. That means prescribing Ozempic for weight alone is off-label in the US. In Brazil, check the current indication in the Anvisa bula, because labels get updated.
Before your appointment, write your main goal in one sentence. Is it blood sugar, weight, heart risk, or a mix? That sentence keeps the conversation focused and gives you something concrete to measure against later.
Review your health history before the first dose
The label opens with a boxed warning titled “RISK OF THYROID C-CELL TUMORS.” Ozempic is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your doctor about any thyroid cancer in your family, including relatives you rarely see.
The label also lists warnings and precautions worth raising: pancreatitis, gallbladder disease, complications in people with diabetic retinopathy, and kidney injury that can follow dehydration from severe gastrointestinal effects. Mention past episodes and any eye or kidney problems you already have, even if they seem minor.
Pregnancy planning matters too. The label advises stopping semaglutide before a planned pregnancy because the drug stays in the body for a while after the last dose. Confirm the exact washout timing in the current label, and if pregnancy is possible in the coming year, say so before you start.
Bring these items to the visit:
- A complete list of current medications and supplements, since insulin or sulfonylureas can change your hypoglycemia risk
- Your most recent labs, including A1C, kidney function, and lipids
- Your family history of thyroid cancer, plus any past pancreatitis or gallbladder problems
- Your one-sentence goal and a written list of questions
Read the trial results with the right questions
Three trial programs matter most. STEP looked at weight outcomes, SUSTAIN looked at glycemic outcomes in type 2 diabetes, and SELECT, published in the New England Journal of Medicine in 2023, tested cardiovascular outcomes. SELECT used the 2.4 mg dose and enrolled people with overweight or obesity and heart disease who did not have diabetes, so check the design before applying it to yourself. Pull every figure straight from the published papers, not from memory or secondary summaries, which often drop the details that matter most.
Ask about relative versus absolute risk reduction. A headline may report a large percentage drop in events, but the absolute difference, meaning how many fewer people had an event out of every hundred treated, can be much smaller. Both numbers belong in your decision.
Then look at who was enrolled. How many people took part, how long the study ran, who dropped out, and how closely participants matched you in age, weight, and existing conditions? Trial populations rarely look exactly like the patients in a clinic. Stay current with our OzemNews coverage of new trial data as results get updated.
Weight regain after stopping is well documented. The STEP extension studies followed people after treatment ended and reported regain, so read the exact discontinuation figures in the published papers before drawing conclusions.
Plan for cost, access, and the long run
Ozempic is usually a long-term treatment, so the real question is what happens when you stop. Ask your doctor what the plan looks like at 6, 12, and 24 months. Will the dose change? Which labs will you need? What happens if the goal is not met, or if you must pause for surgery or pregnancy?
Coverage varies widely. Check whether SUS programs in your state or city include the medication, since rules differ by region. If you have a private health plan, read its formulary (the list of covered drugs) and ask how prior authorization works. The ANS regulates private health plans in Brazil, so it's a useful reference for your rights. Manufacturer programs may exist too, but their terms change. Prices also vary by pharmacy and dose, so check current prices directly instead of trusting old blog numbers. To keep tabs on pricing and coverage news through OzemNews, keep tabs on pricing and coverage news through OzemNews.
Supply matters as well. Some semaglutide products have appeared on shortage lists in recent years, so check the FDA and Anvisa lists before you commit to a plan. Then count the costs beyond the pen: appointments, lab tests, and treatment for side effects like nausea or constipation. A modest pen price can still become an expensive year if the rest of your care is not budgeted.
Four questions to ask at the appointment
What is my target, and how will we measure progress? Ask whether the goal is A1C, weight, waist size, blood pressure, or something else, and how often you'll check it.
Which side effects should make me call you the same day? Ask about label warnings such as severe abdominal pain that doesn't go away, persistent vomiting, and sudden vision changes. Get the after-hours number before you leave the office.
How does the dose go up? The label starts at 0.25 mg once weekly and steps the dose up over several weeks based on how you tolerate it. Ask your doctor to walk through the schedule and confirm it against the current label.
What if I don't reach the goal, and what is my exit plan? Ask how long you'll give the drug before reassessing, what alternatives exist, and how you would stop safely and what support follows.
Review the decision over time, not just at the start
Set review points tied to your dose steps and lab schedule instead of waiting for a yearly visit. Between visits, keep a simple log with weekly weight, glucose readings if you check them, meals, and symptoms. A few lines a day turn vague feelings into data your doctor can use.
Know when to stop and seek care. According to the label, severe persistent abdominal pain can signal pancreatitis, so get medical help promptly. Signs of dehydration, such as dizziness or being unable to keep fluids down, also need a call to your doctor. A sudden change in vision is another reason to seek care right away.
If you want more detail on specific effects, our earlier posts cover diarrhea, hair shedding, and pancreatitis symptoms, so you can read those angles without repeating them here. Revisit the decision whenever your dose changes, your health shifts, or the label is updated. If you want to follow how labels and warnings change over time, the OzemNews archive is a good place to start.
FAQ
Is Ozempic approved for weight loss alone in the US?
No. Ozempic is approved for type 2 diabetes and for lowering cardiovascular risk in people with type 2 diabetes and established heart disease. Wegovy is the product labeled for chronic weight management, so using Ozempic for weight alone is off-label.
Can I take Ozempic if thyroid cancer runs in my family?
Possibly not. The label contraindicates Ozempic in people with a personal or family history of medullary thyroid carcinoma or MEN 2, so tell your doctor about any family history before starting.
Will the weight come back if I stop?
Weight regain after stopping is documented in the STEP extension research. Ask your doctor about a maintenance plan or alternatives, and read the exact figures in the published papers.
Should I stop Ozempic before trying to get pregnant?
The label advises stopping before a planned pregnancy because the drug stays in the body for some time. Confirm the exact timing in the current label with your doctor well in advance.
Sources
- Ozempic (semaglutide) prescribing information, DailyMed (U.S. National Library of Medicine)
- Wegovy (semaglutide) prescribing information, DailyMed
- FDA: Drug Shortages
- FDA: Drugs (approved drug information)
- Anvisa: Agência Nacional de Vigilância Sanitária
- European Medicines Agency: product information (SmPC)
- New England Journal of Medicine (SELECT trial, 2023)
- ANS: Agência Nacional de Saúde Suplementar
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app